Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Challenges and opportunities in evaluating diagnostic tests.

David F Ransohoff1

  • 1University of North Carolina at Chapel Hill, CB #7080 724 Burnett-Womack, Chapel Hill, NC 27599-7080, USA. ransohof@med.unc.edu

Journal of Clinical Epidemiology
|January 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular vesicle and particle-based blood test for ovarian cancer screening of average risk population: a promising nested case control study using preclinical samples.

Gynecologic oncology·2025
Same author

Direct-to-consumer tests: emerging trends are cause for concern.

BMJ (Clinical research ed.)·2024
Same author

Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research.

Journal of the National Cancer Institute·2024
Same author

Multitarget Stool RNA Testing.

JAMA·2024
Same author

An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.

Gut·2023
Same author

In adults, sigmoidoscopy screening invitation reduced CRC incidence and related mortality at 15 y.

Annals of internal medicine·2023
Same journal

Harms Reporting Was Frequently Incomplete or Discordant in Biomedical Randomized Trials Published in 2023: A Meta-epidemiological Study.

Journal of clinical epidemiology·2026
Same journal

Using an Open Science Checklist in Grant Proposal Reviews to Predict Reproducibility of Funded Publications.

Journal of clinical epidemiology·2026
Same journal

A comparison of five statistical methods used to analyse longitudinal EORTC QLQ-C30 quality of life scores in randomised controlled trials: a simulation study.

Journal of clinical epidemiology·2026
Same journal

Sample Size Determination for Decision-centered Pragmatic Trials.

Journal of clinical epidemiology·2026
Same journal

Many multicenter randomized controlled trials do not account for center effect: a methodological review.

Journal of clinical epidemiology·2026
Same journal

Patient Acceptability of the Modified Zelen Approach to Randomized Trials - A Survey of the CAPS THA Cohort.

Journal of clinical epidemiology·2026
See all related articles

Clinical research for diagnostic tests faces evolving challenges. This includes limitations in traditional methods, diverse data needs for decision-makers, and evaluating new molecular tests.

Area of Science:

  • Clinical Epidemiology
  • Diagnostic Test Evaluation
  • Health Research Methods

Background:

  • The evaluation of diagnostic tests has undergone significant evolution over the past 25 years.
  • Traditional approaches in clinical epidemiology for test evaluation have limitations.

Purpose of the Study:

  • To discuss current challenges and opportunities in diagnostic test evaluation research.
  • To explore the impact of decision-maker data utilization on future research.
  • To address specific issues in evaluating molecular-based diagnostic tests.

Main Methods:

  • Review of the evolution of clinical research in diagnostic test evaluation.
  • Analysis of the limitations of traditional clinical epidemiology.
  • Examination of how different decision-makers use epidemiological data.

Related Experiment Videos

  • Discussion of challenges and opportunities in molecular test evaluation.

    • Main Results:

    • Traditional clinical epidemiology has limitations in evaluating diagnostic tests.
    • Decision-makers' varied use of data influences future research directions.
    • Molecular-based tests present unique evaluation challenges and opportunities.

    Conclusions:

    • The field requires adaptation beyond traditional epidemiological focus.
    • Understanding decision-maker needs is crucial for relevant research.
    • Specialized strategies are needed for evaluating novel molecular diagnostics.